Topic
Radiation Segmentectomy
16 Podcasts • 19 Cases • 3 Courses on BackTable
Hear how experienced physicians approach Radiation Segmentectomy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 673 • 08 Sept 2026
Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures.
This podcast is supported by an educational grant from Boston Scientific TheraSphere Y-90.
More on Radiation Segmentectomy
Loading recent podcasts…
Vascular & IR # 673
Sep 7, 2026
with Dr. Ryan Hickey, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can...
1,900+ listens
Vascular & IR # 649
May 26, 2026
with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...
1,600+ listens
Vascular & IR # 642
May 6, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
Vascular & IR # 639
Apr 29, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy
Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...
Vascular & IR # 655
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,800+ listens
Vascular & IR # 644
May 11, 2026
with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...
1,300+ listens
Vascular & IR # 641
May 4, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
2,400+ listens
Vascular & IR # 561
Jul 28, 2025
with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
When is Y90 the right treatment for metastatic disease? Join Drs. Tyler Sandow, Zach Berman and host Kavi Krishnasamy...
2,100+ listens
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Apr 29, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Apr 29, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.